Literature DB >> 10874474

Induction of p53-independent p21 during ceramide-induced G1 arrest in human hepatocarcinoma cells.

W H Kim1, K H Kang, M Y Kim, K H Choi.   

Abstract

Ceramide is known to induce pRb (retinoblastoma gene product) dephosphorylation through the activation of ceramide-activated protein phosphatase (CAPP) during G1 arrest, but other molecular mechanisms linked to regulation of pRb dephosphorylation during ceramide-induced G1 arrest are poorly understood. In this paper, we investigated whether p21, a cdk (cyclin-dependent kinase) inhibitor, is involved in the induction of pRb dephosphorylation during ceramide-induced G1 arrest. In SK-Hep-1 cells, the addition of ceramide resulted in pRb dephosphorylation and G1 arrest. The activity of cdk2 was inhibited in response to ceramide during this process. p21 protein and mRNA were remarkably induced, while the protein level of p53, known as a transcriptional activator of p21, was not elevated at the same condition. p21 induction was also observed in the Hep3B cells lacking a functional p53 after exposure to ceramide. Although p21 is induced in ceramide-treated Hep3B cells, Hep3B cells do not induce G1 arrest, because Hep3B cells are deficient in a functional pRb protein. To confirm that pRb is a critical target for the induction of G1 arrest by inhibiting cdk2 activity through p53-independent p21, pRb-expressing vector was transfected into Hep3B cells. After treatment with ceramide, pRb-expressing cells (pRb+/+), but not pRb-/- cells, were arrested in G1 phase. In pRb+/+ cells, ceramide-mediated G1 arrest was accompanied by the accumulation of hypophosphorylated pRb and p21 associated with cdk2. Together, these results suggest that p21, induced through p53-independent pathway, participates in the induction of pRb dephosphorylation by inhibiting cdk2 activity during ceramide-mediated G1 arrest in hepatocarcinoma cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10874474

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  10 in total

Review 1.  p53 and regulation of bioactive sphingolipids.

Authors:  Linda A Heffernan-Stroud; Lina M Obeid
Journal:  Adv Enzyme Regul       Date:  2010-10-28

Review 2.  Sphingolipids and expression regulation of genes in cancer.

Authors:  Gauri A Patwardhan; Yong-Yu Liu
Journal:  Prog Lipid Res       Date:  2010-10-21       Impact factor: 16.195

Review 3.  Ceramide Signaling and p53 Pathways.

Authors:  Kristen A Jeffries; Natalia I Krupenko
Journal:  Adv Cancer Res       Date:  2018-06-01       Impact factor: 6.242

4.  Protein phosphatase 2A and neutral sphingomyelinase 2 regulate IRAK-1 protein ubiquitination and degradation in response to interleukin-1beta.

Authors:  Aneta Dobierzewska; Natalia V Giltiay; Sathish Sabapathi; Alexander A Karakashian; Mariana N Nikolova-Karakashian
Journal:  J Biol Chem       Date:  2011-06-27       Impact factor: 5.157

Review 5.  Ceramide-orchestrated signalling in cancer cells.

Authors:  Samy A F Morad; Myles C Cabot
Journal:  Nat Rev Cancer       Date:  2012-12-13       Impact factor: 60.716

Review 6.  Integration of glycosphingolipid metabolism and cell-fate decisions in cancer and stem cells: review and hypothesis.

Authors:  Erhard Bieberich
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

7.  Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse.

Authors:  Joseph C Cheng; Aiping Bai; Thomas H Beckham; S Tucker Marrison; Caroline L Yount; Katherine Young; Ping Lu; Anne M Bartlett; Bill X Wu; Barry J Keane; Kent E Armeson; David T Marshall; Thomas E Keane; Michael T Smith; E Ellen Jones; Richard R Drake; Alicja Bielawska; James S Norris; Xiang Liu
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

8.  Cell-cycle arrest in Jurkat leukaemic cells: a possible role for docosahexaenoic acid.

Authors:  Rafat A Siddiqui; Laura J Jenski; Kevin A Harvey; Jacqueline D Wiesehan; William Stillwell; Gary P Zaloga
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

9.  Ceramide modulates pre-mRNA splicing to restore the expression of wild-type tumor suppressor p53 in deletion-mutant cancer cells.

Authors:  Gauri A Patwardhan; Salman B Hosain; David X Liu; Sachin K Khiste; Yunfeng Zhao; Jacek Bielawski; S Michal Jazwinski; Yong-Yu Liu
Journal:  Biochim Biophys Acta       Date:  2014-09-06

10.  The role of cyclin D2 and p21/waf1 in human T-cell leukemia virus type 1 infected cells.

Authors:  Kylene Kehn; Longwen Deng; Cynthia de la Fuente; Katharine Strouss; Kaili Wu; Anil Maddukuri; Shanese Baylor; Robyn Rufner; Anne Pumfery; Maria Elena Bottazzi; Fatah Kashanchi
Journal:  Retrovirology       Date:  2004-04-13       Impact factor: 4.602

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.